Cargando…

Epigenetic Biomarkers in Cancer

Detalles Bibliográficos
Autores principales:	Cheng, Yuen Yee, Jin, Hong Chuan, Chan, Michael W. Y., Chu, Wai Kit, Grusch, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838454/ https://www.ncbi.nlm.nih.gov/pubmed/29675115 http://dx.doi.org/10.1155/2018/4987103

Ejemplares similares

DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer
por: Leygo, Catherine, et al.
Publicado: (2017)

The Use of Epigenetic Biomarkers as Diagnostic and Therapeutic Options
por: Zhang, Le, et al.
Publicado: (2022)

Cancer Epigenetic Biomarkers
por: Coppedè, Fabio
Publicado: (2023)

Firing up Cold Tumors—Targeting the Epigenetic Machinery to Enhance Cancer Immunotherapy
por: Lin, Guan-Ling, et al.
Publicado: (2021)

Editorial: Epigenetic Modifications in Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2021)

Roles of Methylated DNA Biomarkers in Patients with Colorectal Cancer
por: Ma, Zhiyao, et al.
Publicado: (2019)

Environmental Epigenetics
por: Skinner, Michael K.
Publicado: (2015)

Environmental Epigenetics update
por: Skinner, Michael K
Publicado: (2018)

Environmental Epigenetics update
por: Skinner, Michael K
Publicado: (2021)

Epigenetic aging in oocytes
por: Wasserzug-Pash, Peera, et al.
Publicado: (2023)

Epigenetics of Urological Cancers
por: Schulz, Wolfgang A., et al.
Publicado: (2019)

Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
por: Ho, Bo Man, et al.
Publicado: (2022)

Environmental Epigenetics Update and Boards
por: Skinner, Michael K
Publicado: (2019)

Environmental Epigenetics 2022 update
por: Skinner, Michael K
Publicado: (2022)

Environmental Epigenetics 2023 update
por: Skinner, Michael K
Publicado: (2023)

Environmental epigenetics and climate change
por: Skinner, Michael K
Publicado: (2022)

Epigenetic Regulation in Reproductive Medicine and Gynecologic Cancers
por: Jiang, Shi-Wen, et al.
Publicado: (2010)

The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
por: Cheng, Yuen Yee, et al.
Publicado: (2020)

SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2017)

Editorial: NAR Cancer and epigenetics and cancer
por: Yang, Danzhou, et al.
Publicado: (2022)

Special Issue: Cancer Biomarkers and Targets in Digestive Organs
por: Yee, Nelson S., et al.
Publicado: (2019)

Epigenetic biomarkers in cancer
por: Egger, Gerda
Publicado: (2018)

Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer
por: Wei, Kuo-Liang, et al.
Publicado: (2019)

Epigenetic basis of cancer drug resistance
por: Aziz, Moammir H., et al.
Publicado: (2020)

PCDHB15 as a potential tumor suppressor and epigenetic biomarker for breast cancer
por: Chiang, Ching-Chung, et al.
Publicado: (2022)

Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers
por: Tran, Mita T. M. T., et al.
Publicado: (2021)

The landscape of genetics and biomarkers in bladder cancer
por: Rink, Michael
Publicado: (2017)

How big is the ‘next big thing’? Estimating the burden of non–communicable diseases in low– and middle–income countries
por: Chan, Kit Yee, et al.
Publicado: (2012)

Switching off Cancer: Is There a Role for Epigenetics?
por: Avery-Kiejda, Kelly A.
Publicado: (2021)

Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers
por: Li, Jiaqiu, et al.
Publicado: (2014)

Anesthetics and epigenetics
por: Sen, Nilkantha
Publicado: (2016)

The Epigenetics Dilemma
por: Grunau, Christoph, et al.
Publicado: (2019)

A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma
por: Schelch, Karin, et al.
Publicado: (2017)

Epigenetics and cancer disparities: when nature might be nurture
por: Jordan, I. King, et al.
Publicado: (2022)

Biomarkers and subtypes of cancer
por: Starmans, Maud H.W., et al.
Publicado: (2015)

Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy
por: Goldstein, Michael
Publicado: (2023)

Biomarkers for bladder cancer: The search continues!
por: Hong, Sung Kyu
Publicado: (2016)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
por: Kumari, Himani, et al.
Publicado: (2020)

DNA Methylation Induced Epigenetic Silencing: A Potential Biomarker and Therapeutic Target for Head and Neck Squamous Cell Carcinoma
por: Patil, Shankargouda, et al.
Publicado: (2015)

An Epigenetic Regulator: Methyl-CpG-Binding Domain Protein 1 (MBD1)
por: Li, Lu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3sojq3ha0f4g1iokhtfthr7tv0